Status:
COMPLETED
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
Ludwig Boltzmann Gesellschaft
Conditions:
Pulmonary Arterial Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to determine relevant hemodynamic parameters for the diagnostics of pulmonary arterial hypertension (PAH) by dynamic contrast enhanced dual-energy CT (DE-CT). In this prospecti...
Detailed Description
Pulmonary arterial hypertension (PAH) is a rare, life-threatening disease. It is characterized by the elevation of pulmonary arterial pressure and pulmonary vascular resistance. A remodeling of small ...
Eligibility Criteria
Inclusion
- patients with right heart catheterization data
Exclusion
- patients with decreased renal function
- patients who received CT in the previous six months
- intolerance of contrast material
- other standard CT contraindications
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT01829672
Start Date
March 1 2013
End Date
March 1 2017
Last Update
July 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Graz, Division of Pulmonology
Graz, Styria, Austria, 8010